AlisonRaeMoliternoMD

Associate Professor of Medicine, Johns Hopkins University School of Medicine

Dr. Moliterno is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1992 - 1994
Johns Hopkins University/Bayview Medical CenterResidency, Internal Medicine, 1989 - 1992
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1989

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

PubMed

189 citations
Platelet counts differ by sex, ethnicity, and age in the United States.
Jodi B Segal, Alison R. Moliterno
Annals of Epidemiology. 2006-02-01
4 citations
Continuous-infusion von Willebrand factor concentrate is effective for the management of acquired von Willebrand disease.
Kathryn Dane, John Lindsley, Thomas S. Kickler, Michael B. Streiff, Alison R. Moliterno
Blood Advances. 2021-07-27
9 citations
The role of the atypical chemokine receptor CCRL2 in myelodysplastic syndrome and secondary acute myeloid leukemia.
Theodoros Karantanos, Patric Teodorescu, Brandy Perkins, Ilias Christodoulou, Christopher Esteb
Science Advances. 2022-02-18

Abstracts/Posters

High Mobility Group A1 Chromatin Regulators: Key Epigenetic Switches and Therapeutic Targets Required for Leukemic Transformation in JAK2 Mutant MPN
Alison R. Moliterno, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
ATM Germline Variant Increases the Risk of MPN Progression
Alison R. Moliterno, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Worse Outcomes in Males with MPN Are Associated with Qualitative and Quantitative Differences in Non-Driver Mutational Burden
Alison R. Moliterno, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

High Mobility Group A1 Chromatin Remodeling Proteins Amplify Inflammatory Networks to Drive Leukemic Transformation in Chronic Myeloproliferative Neoplasia in Humans a...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Independent Association of Male Sex with Presentation and Clinical Outcomes in Myeloproliferative Neoplasms
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018